Pharmacyte Biotech Inc (OTCMKTS:PMCB) Announces Major Milestones Right Before Phase 2b Clinical Trial in Pancreatic Cancer Starts

Pharmacyte Biotech Inc (OTCMKTS:PMCB) is about to start the phase 2b clinical trial in pancreatic cancer. Before it initiates, the company wants its investors and customers to know some of the major milestones it’s working on and craves to attain down the line. Milestones Some of the major steps that Pharmacyte intends to take are […]